Multi-center study of ILUVIEN implant treatments demonstrates improvements for patients with vision loss due to diabetic macular edema

2018-10-09T22:41:23-04:00October 9th, 2018|Categories: Media Relations, News, Public Relations|Tags: , , , , , |

Retina Health Center has presented results of a national, multi-center study of ILUVIEN involving retinal patients from four centers including Cincinnati Eye, Georgia Retina, Retina Health Center and Southern Eye. The findings of the study were presented at the 18th EURETINA Congress in Vienna, Austria by Dr. Alexander Eaton, founder and director of Retina Health [...]

Retina Health Center now accepting patients for clinical trial of new pill for wet age-related macular degeneration

2016-11-08T14:59:05-05:00August 22nd, 2016|Categories: Public Relations|Tags: , , , , , , , , , |

Retina Health Center is now accepting patients for a clinical trial for a new pill, X-82, for the treatment of wet age-related macular degeneration (AMD). Current treatments for wet AMD include three drugs that are injected into the eye that stop the growth of blood vessels, targeting VEGF, a growth factor that contributes to new [...]

Go to Top